Article in press - uncorrected proof
J Lab Med 2005;29(4):229–234 2005 by Walter de Gruyter • Berlin • New York. DOI 10.1515/JLM.2005.031 2005/32
Point-of-Care-Testing Redaktion: R. Junker
Novel applications of the intraoperative parathyroid hormone
Neue Anwendungen des intraoperativen Parathormon-Assays
Melanie L. Richards* and Juliane Bingener ¨ ¨
Schlusselworter: Hyperparathyreoidismus; Hypokalzia-¨
mie; intraoperatives Parathormon; Parathyreoidektomie;
Department of Surgery, University of Texas Health
Science Center at San Antonio, San Antonio, USA
The development of an accurate and rapid method to The concept of monitoring parathyroid hormone (PTH)
measure parathyroid hormone (PTH) utilizing a two-site levels intraoperatively was first described by Nussbaum
immunochemiluminometric assay (ICMA) has expanded in 1988 w1x. Several years later, in 1992, the intraoperative
its use to point-of-care testing. Measuring parathyroid parathyroid hormone (IOPTH) assay was introduced to
hormone can be utilized to determine the completeness the clinical setting using a modified immunoradiometric
of parathyroid resection, to regionalize hypersecreting assay (IRMA) to measure the whole molecule PTH w2x.
parathyroid glands, to identify parathyroid glands on fine- This method was advantageous over frozen section
needle aspiration, and as a predictor of postoperative results because it identified a biochemical cure. However,
hypocalcemia following thyroidectomy and parathyroid- it was limited by the time it spent to obtain a result
ectomy. This review addresses the current utilization of (60 min). In 1994, Irvin and Deriso reported their results
these techniques in patients with thyroid and parathyroid using a two-site immunochemiluminometric assay
disease. (ICMA) to measure the active component of PTH, 1-84
PTH, also referred to as the intact-PTH w3x. The ICMA
Keywords: hyperparathyroidism; hypocalcemia; intra- provided IOPTH results in less than 15 min and had a
operative parathyroid hormone; parathyroidectomy; sensitivity of 94% for predicting postoperative calcium
thyroidectomy. levels. Since that time, the IOPTH assay has undergone
several modifications to reduce the assay’s detection of
PTH fragments in order to improve its specificity and
Zusammenfassung sensitivity w4x. The development of this accurate and rap-
id assay broadened its applicability to point-of-care test-
Die Entwicklung praziser und schneller Methoden zur
¨ ing. In this setting it has been utilized to determine the
Bestimmung des Parathormons (PTH) mittels Immun- completeness of parathyroid resection, to regionalize
chemoluminiszenz ermoglicht die Anwendung dieser
¨ hypersecreting parathyroid glands, to identify parathyroid
Bestimmung in der patientennahen Diagnostik. Die glands on fine-needle aspiration, and as a predictor of
Bestimmung erfolgt zur Uberprufung der vollstandigen
¨ ¨ postoperative hypocalcemia following thyroidectomy and
Resektion der Nebenschilddruse, zur Lokalisierung
¨ parathyroidectomy. This review will discuss the current
hypersekretorischer Nebenschilddrusen, zur Kontrolle bei
¨ utilization of these techniques in thyroid and parathyroid
Feinnadelbiopsien und zur Abschatzung einer zu erwar-
tenden postoperativen Hypokalzamie nach Resektion
von Schilddruse oder Nebenschilddrusen. Die vorliegen-
¨ ¨ Post-thyroidectomy
de Ubersicht stellt aktuelle Einsatzgebiete der patienten-
nahen PTH-Bestimmung dar. The most common complication following a total thy-
roidectomy is hypoparathyroidism, with hypocalcemia
*Correspondence: Melanie L. Richards, MD, University of occurring in up to 11–87% of patients w5–8x. The hypo-
Texas Health Science Center at San Antonio, 7703 Floyd Curl, parathyroidism is transient and will resolve in the majority
San Antonio, TX 78229, USA
(80–90%) of cases w5, 9x. However, it is the common
Tel.: q1 210-567-5730
Fax: q1 210-567-5797 cause for a prolonged hospitalization and readmission
E-mail: firstname.lastname@example.org following total thyroidectomy. The onset of hypocalcemia
Article in press - uncorrected proof
230 M.L. Richards and J. Bingener: Novel applications of the intraoperative parathyroid hormone assay
Table 1 Utilization of the intraoperative parathyroid hormone assay to predict post-thyroidectomy hypocalcemia.
Reference Protocol Predicting hypocalcemia
Richards 2003 Single PTH level obtained 10 min 80% 100%
post total thyroidectomy
measured -10 pg/mL
Lindblom 2002 Single PTH level obtained post 71% 81%
total thyroidectomy measured
below the reference level
Lo 2002 Decline in PTH level )75% 100% 72%
from induction to 10 min
post total thyroidectomy
and its associated symptoms will usually occur within Lindblom et al. also used the IOPTH assay immediately
6–24 h after the operation. Investigators who have eval- following near-total or total thyroidectomy w17x. They
uated serial calcium levels to identify a downward trend reported that an IOPTH level below the reference level
or actual hypocalcemia have found that they are usually predicted symptomatic hypocalcemia. A comparison
not helpful until 12–24 h postoperatively w10–12x. A pro- was made between the IOPTH level and a serum calcium
longed delay in identification of symptomatic patients will on postoperative day one. The IOPTH had a higher sen-
prolong the length of hospitalization because earlier sup- sitivity and specificity (71% vs. 52% and 81% vs. 76%).
plementation facilitates an earlier discharge. The short This sensitivity may be further increased if the PTH level
half-life of PTH (on the average, less than 2 min) and the is sent later in the postoperative period, but early enough
ability to obtain a timely result with the rapid PTH assay to initiate supplementation prior to the development of
prompted investigators to evaluate its application to pre- symptomatic hypocalcemia. Lam and Kerr measured a
dict post-thyroidectomy hypocalcemia w13x. PTH level at one hour post-thyroidectomy w18x. All pa-
tients who had a level below 8 pg/mL developed hypo-
Single PTH measurement calcemia and all patients with a level above 9 pg/mL were
normocalcemic. The sensitivity can be further increased
Our practice over the past four years has been to mea- by broadening the range of PTH values associated with
sure the IOPTH levels following closure of the skin inci- hypocalcemia. Toniato et al. recommended that the rapid
sion, approximately 10 min after the thyroid has been PTH assay should be used on postoperative day one
removed. With this technique we found that the patients w19x. They found that a PTH level below 16 pg/mL, rather
who developed symptomatic hypocalcemia had signifi- than 10 pg/mL, identified 8.6% more patients with hypo-
cantly lower IOPTH levels than the asymptomatic calcemia. The sensitivity and specificity of the IOPTH
patients (mean IOPTH 7.6"12.0 versus 55.7"31.8, p may also vary between assays because of differing ref-
-0.05) w9x. Overall, this method was found to be 80% erence ranges. For example, the Elecsys 2010 assay has
sensitive and 100% specific for predicting hypocalcemia. a reference range of 1.6–6.9 pmol/L and the Immulite
An IOPTH value -10 pg/mL had a positive predictive assay reference range is 12–72 pg/mL. The techniques
value of 100% and a negative predictive value of 91% of measuring sequential PTH levels have also shown to
for detecting patients at risk for symptomatic hypocal- be useful in the clinical setting.
cemia w9x. Table 1 compares this method to several other
techniques that will be discussed. Sequential PTH levels
A single post-thyroidectomy IOPTH method was cho-
sen to obviate the possible impact of fluid administration Lo et al. evaluated 100 patients undergoing a total or
or sedative agents on the IOPTH level and its decline. completion thyroidectomy using a method of sequential
The primary agent in question is propofol (2,6-diisopro- IOPTH levels w5x. They obtained an IOPTH after the
pylphenol). It has been reported that propofol increases induction of anesthesia, at zero and 10 min post-thyroid-
PTH levels in normocalcemic patients w14x. There were ectomy, and at one day postoperatively. The 11 patients
also conflicting results in patients with primary and sec- who developed symptomatic hypocalcemia had signifi-
ondary hyperparathyroidism (HPT). Sokoll et al. found cantly lower immediate post-thyroidectomy PTH levels
that propofol present at dilutions of 5 to 40% resulted in and a significantly higher percentage decline in the PTH
PTH levels that were 53 to 90% of the actual value w15x. from the induction values (mean, 88.6% vs. 38.1%). At
Sipple et al. evaluated the effect of propofol on IOPTH 10 min post-thyroidectomy the mean percentage of
levels in patients with secondary HPT undergoing dialysis decline was 96.3% in the patients with symptomatic
access procedures and found no significant effect on hypocalcemia and 47.5% in the asymptomatic patients.
IOPTH levels w16x. In our own experience, propofol given The authors found that a )75% decline at 10 min post-
at induction will increase the IOPTH level significantly thyroidectomy was 100% sensitive, 72% specific and
above the IOPTH level obtained 10 min after induction. 75% accurate for predicting hypocalcemia. Higgins et al.
Article in press - uncorrected proof
M.L. Richards and J. Bingener: Novel applications of the intraoperative parathyroid hormone assay 231
measured IOPTH levels at 5, 10 and 20 min post-thy- important to recognize that the average PTH half-life is
roidectomy w20x. There were significant differences in the variable. In a kinetic analysis of 45 patients with HPT,
rates of decline between patients that did and did not the PTH half-life ranged from 0.4–3.8 min (mean,
require calcium supplementation at each time period. 1.68"0.94 min) w13x. This variability led the authors to
However, the rate of decline for the IOPTH levels drawn recommend a kinetic analysis for improved accuracy in
at 20 min post-thyroidectomy was the most predictive, determining a curative operation.
identifying 64% of patients who would require calcium From these studies in primary HPT it is evident that a
supplementation. These results were confirmed by other limited parathyroid exploration in conjunction with the
investigators and it was proposed that these patients be IOPTH assay has been shown to have equivalent suc-
considered for autotransplantation because of the ques- cess to a four-gland exploration. In addition, it has sig-
tionable viability of the remaining parathyroid glands w21x. nificantly reduced the cost of surgery by decreasing the
The selection of parathyroid glands for autotransplanta- number of frozen sections, decreasing the length of hos-
tion should be undertaken with caution because the vast pital stay, and allowing for local anesthesia w24x.
majority of patients will have reversal of their hypopara-
thyroid state. Secondary hyperparathyroidism
The ability of sequential or early postoperative PTH
levels to predict which patients will develop symptomatic The IOPTH assay has been controversial in secondary
hypocalcemia w5, 9x allows the clinician to initiate calcium HPT (2HPT) because of the presence of multiglandular
and possible calcitriol supplementation prior to the onset disease and the variability of PTH degradation kinetics in
of symptoms. It also identifies a subgroup of patients patients with renal disease and 2HPT. This has led some
who may not be candidates for early discharge. The investigators to conclude that there is no role for the
measurement of IOPTH levels post-thyroidectomy is the IOPTH assay in surgery for 2HPT because there is no
earliest predictor of symptomatic hypocalcemia. correlation between the IOPTH and the PTH obtained on
postoperative day one w31x. However, studies have
Primary hyperparathyroidism shown that the IOPTH level in patients with 2HPT does
degrade at a rate (85% average decline from baseline)
The ‘‘gold standard’’ operation for parathyroidectomy has allowing for intraoperative utilization of the criterion re-
been a four-gland exploration, which in the hands of an commended in 1HPT w32, 33x. This was confirmed when
experienced surgeon will have a success rate of 95%. In Chou et al. demonstrated that the IOPTH at 10 min was
the mid-90s, the IOPTH assay with a limited exploration as accurate as one obtained 30 min post-excision w34x.
in sporadic primary hyperparathyroidism (1HPT) rivaled The two operations most commonly performed for
the four-gland exploration and became a new standard 2HPT are a subtotal parathyroidectomy and a total para-
of care. thyroidectomy. The goals of each operation are different
The accept criterion for biochemical success is a 50% and require separate strategies for utilizing the IOPTH
reduction from the highest pre-excision IOPTH level assay. Theoretically, the post-excision IOPTH level in
when the sample is drawn 10 min after the abnormal patients undergoing a subtotal parathyroidectomy should
parathyroid tissue is removed w1, 15, 22x. Cure rates fall more than 50% from the pre-excision levels and be
range from 97 to 100% in patients who have sporadic as close to the normal range as possible. To ensure a
1HPT and undergo a directed parathyroidectomy based complete total parathyroidectomy, the criterion for 2HPT
on the IOPTH criterion of )50% decline from baseline is more stringent, as a )60% reduction in IOPTH has
w23–27x. In addition, a few investigators recommend that been recommended w34x.
the post-excision PTH should be within the normal range The IOPTH is a useful adjunct for guiding the com-
w28x. The IOPTH assay has been a questionable predictor pleteness of resection in 2HPT and may reduce the inci-
of multiglandular disease. In Irvin’s 2004 update, he dence of persistent and recurrent 2HPT. However, as with
found that patients undergoing a limited exploration had familial forms of HPT, the stimuli for hyperplasia will per-
significantly fewer rates of multiglandular disease (3% vs. sist until the patient undergoes renal transplantation and
10%) when compared to those who had undergone a then they may develop autonomously functioning hyper-
four-gland exploration w23x. This was likely a result of pre- plastic parathyroid glands and tertiary HPT (3HPT).
selection bias, as the majority of patients undergoing a
limited exploration had localization on preoperative imag- Tertiary hyperparathyroidism
ing. Despite this finding, the incidence of recurrent HPT
was comparable between the two groups (3% and 4%). The application of the IOPTH in 3HPT has been rarely
There have been several reports in which the drop in the reported. In our practice we have utilized the IOPTH in
IOPTH suggested a biochemical cure, but the patient had patients with 3HPT because the hyperplasia is generally
evidence of multiglandular disease w29, 30x. This sug- asymmetrical and amenable to a limited exploration. We
gests that there may be pathologically confirmed hyper- have found the PTH degradation kinetics in patients with
cellular parathyroid glands which are not hypersecreting 3HPT to be comparable to those with 1HPT. The average
PTH. When assessing the drop in IOPTH levels, it is also PTH decrease from the baseline value was 85% in 1HPT
Article in press - uncorrected proof
232 M.L. Richards and J. Bingener: Novel applications of the intraoperative parathyroid hormone assay
Table 2 Recommendations on utilizing the intraoperative parathyroid hormone assay in hyperparathyroidism.
Clinical usage Reference IOPTH protocol Cure rates
Sporadic primary Irwin 2004 Decline in IOPTH level 97–100%
hyperparathyroidism Johnson 2001 )50% from baseline to
Vignalli 2001 10 min post-excision
Secondary Chou 2002 Decline in IOPTH level 100%
hyperparathyroidism )60% from baseline to
10 min post-excision
Tertiary Richards 2005 Decline in IOPTH level 100%
hyperparathyroidism )50% from baseline to normocalcemic
10 min post-excision
Familial Carneiro 2002 Decline in IOPTH level 91%
hyperparathyroidism )50% from baseline to
10 min post-excision
Multiglandular Gauger 2004 Regression-based Identifies 54%
disease nomogram of PTH of patients with
degradation kinetics at multiglandular
baseline and 10 min disease
and 89% in 3HPT (unpublished data). Interestingly, at method, it was also possible to identify more patients
10 months follow up, 50% of patients with 3HPT had with multiglandular disease than by relying solely on a
inappropriate elevations in PTH levels and 100% of 50% drop from the baseline values (54% vs. 38%).
patients were normocalcemic. This finding may be relat- A summary of the recommendations for utilizing the
ed to an underlying total calcium or vitamin D deficiency. IOPTH assay in the different types of HPT is presented
Patients with this biochemical profile have been shown in Table 2.
to have reductions of the PTH levels when they are
placed on calcium and vitamin D supplementation w35x.
Normocalcemia is the benchmark of a successful oper-
ation and patients with 3HPT can be successfully treated
with a limited parathyroid exploration in conjunction with
The other side to the 97–100% success rates in para-
the IOPTH criterion.
thyroid surgery is the 0–3% rate of failure. The para-
thyroidectomy for recurrent or persistent hyperpara-
Familial hyperparathyroidism-multiple gland disease
thyroidism is a challenging operation. The success rates
The patients with familial HPT will have either a Multiple are reduced and the morbidity is increased at reoper-
Endocrine Neoplasia (MEN 1 or MEN 2) or familial iso- ation. To improve success, the endocrine surgeon has
lated HPT. These two distinct entities have historically utilized a multimodality armamentarium of localizing pro-
been evaluated as one group. However, the patients with cedures. These have included: technetium-99m sesta-
MEN 1 are at a higher risk for persistent or recurrent HPT mibi scintigraphy with or without single-photon emission
compared to those with MEN 2 or familial isolated HPT. computed tomography, ultrasonography, computed
This has led to a more conservative parathyroidectomy tomography scanning, magnetic resonance imaging, and
in these latter two groups. While these groups are at risk selective venous sampling. Ideally, the surgeon will know
for recurrent disease, a limited parathyroidectomy in where the hyperplastic parathyroid tissue is located prior
familial isolated HPT performed with IOPTH guidance has to surgery. However, he will not have knowledge of the
been shown to have an operative success rate of 93% function or presence of the remaining normal parathyroid
and a short-term (less than 6 months) recurrent HPT rate glands. The use of the parathyroid hormone testing
of 9% w36x. These results are similar to those obtained extends throughout the care of the patient. If necessary,
with a subtotal or total parathyroidectomy with autotrans- the rapid PTH testing allows the opportunity for the
plantation. This group of patients was also found to have selective venous sampling in the immediate post-
a curative operation with a unilateral neck exploration operative period. The immediate results allow for early
80% of the time. Therefore, these investigators recom- re-exploration, which may reduce the likelihood of
mended consideration of jugular venous sampling for encountering a severe inflammatory reaction. Intraoper-
PTH to determine which side of the neck to explore first. atively, the surgeon can also perform jugular venous
The utilization of decay kinetics has also been applied to sampling to assist in regionalizing the hypersecreting
patients with multiglandular 1HPT. These patients appear parathyroid tissue to one side of the neck. In addition to
to have a more gradual decay slope compared to those predicting a curative operation, the IOPTH can also be
patients with a sporadic adenoma w37x. By using this utilized to predict patients at risk for severe hypocalcemia
Article in press - uncorrected proof
M.L. Richards and J. Bingener: Novel applications of the intraoperative parathyroid hormone assay 233
secondary to hypoparathyroidism. There is a 37% risk of 8. Sahai A, Symes A, Jeddy T. Short-stay thyroid surgery. Br
developing symptomatic hypocalcemia after a reopera- J Surg 2005;92:58–9.
9. Richards ML, Bingener-Casey J, Pierce D, Strodel WE,
tion w38x. Following reoperation, Elavaj et al. found that
Sirinek KR. Intraoperative parathyroid hormone assay: An
the post-excision IOPTH which has dropped 84% or accurate predictor of symptomatic hypocalcemia following
greater from baseline has a positive predictive value of thyroidectomy. Arch Surg 2003;138:632–6.
46% for identifying patients with single gland disease 10. Marohn MR, LaCivita KA. Evaluation of total/near-total thy-
that will require supplementation w38x. In patients with roidectomy in a short-stay hospitalization: safe and cost-
multiple gland disease, this 84% reduction was associ- effective. Surgery 1995;118:943–8.
ated with a 71% chance of requiring supplementation. In 11. Moore C, Lampe H, Agrawal S. Predictability of hypocal-
cemia using early postoperative serum calcium levels. J
addition to calcium and calcitriol supplementation,
patients with undetectable or extremely low levels of PTH 12. Bentrem DJ, Rademaker A, Angelos P. Evaluation of serum
should be considered for a parathyroid autograft or cryo- calcium levels in predicting hypoparathyroidism after total/
preservation. The autograft can be implanted in the sub- near-total thyroidectomy or parathyroidectomy. Am Surg
cutaneous tissue and easily excised if the patient has 2001;67:249–52.
return of parathyroid function. An early PTH level will be 13. Libutti SK, Alexander HR, Bartlett DL, Sampson ML, Rud-
del ME, Skarulis M, et al. Kinetic analysis of the rapid
an indicator of native parathyroid function, as the auto-
intraoperative parathyroid hormone assay in patients dur-
graft will generally take 2-4 weeks to produce PTH. ing operation for hyperparathyroidism. Surgery 1999;
14. Zaloga GP, Youngs E, Teres D. Propofol-containing seda-
Conclusion tives increase levels of parathyroid hormone. Intensive
Care Med 2000;26(Suppl 4):S405–12.
Investigators have been challenged with defining the use 15. Sokoll LJ, Drew H, Udelsman R. Intraoperative parathyroid
of the IOPTH assay in both parathyroid and thyroid oper- hormone analysis: A study of 200 consecutive cases. Clin
ations. They have met this challenge by finding success
16. Sippel RS, Becker YT, Odorico JS, Springman SR, Chen
in utilizing the IOPTH assay as an adjunct for predicting H. Does propofol anesthesia affect intraoperative parathy-
and guiding a curative operation for HPT. They have also roid hormone levels? A randomized, prospective trial. Sur-
shown that the IOPTH assay can assist in identifying gery 2004;136:1138–42.
patients at risk for hypocalcemia following both thyroid- 17. Lindblom P, Westerdahl J, Bergenfelz A. Low parathyroid
ectomy and parathyroidectomy. This success in applying hormone levels after thyroid surgery: a feasible predictor
of hypocalcemia. Surgery 2002;131:515–20.
the IOPTH assay to point-of-care medicine has brought
18. Lam A, Kerr PD. Parathyroid hormone: An early predictor
many advances to the surgical care of patients with thy- of postthyroidectomy hypocalcemia. Laryngoscope 2003;
roid and parathyroid disease. 113:2196–200.
19. Toniato A. Importance of early intraoperative parathyroid
hormone assay. Arch Surg 2004;139:343.
References 20. Higgins KM, Mandell DL, Govindaraj S, Genden EM,
Mechanick JI, Bergman DA, et al. The role of intraoperative
rapid parathyroid hormone monitoring predicting thyroid-
1. Nussbaum SR, Thompson AR, Hutcheson KA, Gaz RD, ectomy-related hypocalcemia. Arch Otolaryngol Head
Wang CA. Intraoperative measurement of parathyroid hor- Neck Surg 2004;130:63–7.
mone in the surgical management of hyperparathyroidism. 21. Casella C, Talarico C, Di Fabio F, Bugari G, Iacobello C,
Surgery 1988;104:1121–7. Albertini A, et al. Hypoparathyroidism following total thy-
2. Ryan MF, Jones SR, Barnes AD. Clinical evaluation of a roidectomy: prognostic value of intraoperative hormone
rapid parathyroid hormone assay. Ann Clin Biochem assay. Annali Italiani di Chirurgia 2004;75:23–7.
1992;29:48–51. 22. Irvin GL 3rd, Dembrow VD, Prudhomme DL. Clinical use-
3. Irvin GL, Deriso GT. A new, practical intraoperative para- fulness of an intraoperative ‘‘quick parathyroid hormone’’
thyroid hormone assay. Am J Surg 1994;168:466–8. assay. Surgery 1993;114:1019-22;discussion 1022–3.
4. Gao P, Scheibel S, D’Amour P, John MR, Rao SD, 23. Irvin GL 3rd, Carneiro DM, Solorzano CC. Progress in the
Schmidt-Gayk H, et al. Development of a novel immuno- operative management of sporadic primary hyperparathy-
radiometric assay exclusively for biologically active whole roidism over 34 years. Ann Surg 2004;239:704-8;discus-
parathyroid hormone 1-84: implications for improvement sion 708–11.
of accurate assessment of parathyroid function. J Bone 24. Johnson LR, Doherty G, Lairmore T, Moley JF, Brunt LM,
Min Research 2001;16:605–14. Koenig J, et al. Evaluation of the performance and clinical
5. Lo CK, Luk JM, Tam SC. Applicability of intraoperative impact of a rapid intraoperative parathyroid hormone
parathyroid hormone assay during thyroidectomy. Ann assay in conjunction with preoperative imaging and con-
Surg 2002;5:564–9. cise parathyroidectomy. Clin Chem 2001;47:919–25.
6. Bhattacharyya N, Fried MP. Assessment of the morbidity 25. Vignali E, Picone A, Materazzi G, Steffe S, Berti P, Cian-
and complications of total thyroidectomy. Arch Otolaryngol ferotti L, et al. A quick intraoperative parathyroid hormone
Head Neck Surg 2002;128:389–92. assay in the surgical management of patients with primary
7. Szubin L, Kacker A, Kakani R, Komisar A, Blaugrund S. hyperparathyroidism: a study of 206 consecutive cases.
The management of post-thyroidectomy hypocalcemia. Eur J Endo 2002;146:783–8.
Eur Nose Throat J 1996;75:612–6. 26. Burkey SH, Van Heerden JA, Farley DR, Thompson GB,
Article in press - uncorrected proof
234 M.L. Richards and J. Bingener: Novel applications of the intraoperative parathyroid hormone assay
Grant CS, Curlee KJ. Will directed parathyroidectomy util- rent disease in 304 patients. Langenbecks Arch Surg 2003;
izing the gamma probe or intraoperative parathyroid hor- 387:348–54.
mone assay replace bilateral cervical exploration as the 33. Clary BM, Garner SC, Leight GS Jr. Intraoperative para-
preferred operation for primary hyperparathyroidism? thyroid hormone monitoring during parathyroidectomy for
World J Surg 2002;26:914–20. secondary hyperparathyroidism. Surgery 1997;122:1034-
27. Udelsman R, Donovan PI, Sokoll LJ. One hundred con- 8;discussion 1038–9.
secutive minimally invasive parathyroid explorations. Ann 34. Chou FF, Lee CH, Chen JB, Hsu KT, Sheen-Chen SM.
Surg 2000;232:331–9. Intraoperative parathyroid hormone measurement in
28. Pellitteri PK. Directed parathyroid exploration: evolution patients with secondary hyperparathyroidism. Arch Surg
and evaluation of this approach in a single-institution 2002;137:341–4.
review of 346 patients. Laryngoscope 2003;113:1857–69. 35. Carty SE, Roberts MM, Virji MA, Haywood L, Yim JH. Ele-
29. Haciyanli M, Lal G, Morita E, Duh QY, Kebebew E, Clark vated serum parathyroid hormone level after ‘‘concise
OH. Accuracy of preoperative localization studies and parathyroidectomy’’ for primary sporadic hyperpara-
intraoperative parathyroid hormone assay in patients with thyroidism. Surgery 2002;132:1086–93.
primary hyperparathyroidism and double adenoma. J Am 36. Carneiro DM, Irvin GL, Inabnet WB. Limited versus radical
Coll Surg 2003;197:739–46. parathyroidectomy in familial isolated primary hyperpara-
30. Gauger PG, Agarwal G, England BG, Delbridge LW, Matz thyroidism. Surgery 2002;132:1050-4;discussion 1055.
KA, Wilkinson M, et al. Intraoperative parathyroid hormone 37. Gauger PG, Mullan MH, Thompson NW, Doherty GM, Matz
monitoring fails to detect double parathyroid adenomas: a KA, England BG. An alternative analysis of intraoperative
2-institution experience. Surgery 2001;130:1005–10. parathyroid hormone data may improve the ability to
31. Walgenbach S, Junginger T. Intraoperative parathyroid detect multiglandular disease. Arch Surg 2004;139:164-9.
hormone monitoring in neck exploration for renal hyper- 38. Elaraj DM, Remaley AT, Simonds WF, Skarulis MC, Libutti
parathyroidism? Chirurg 2002;73:211–6. SK, Bartlett DL, et al. Utility of rapid intraoperative para-
32. Dotzenrath C, Cupisti K, Goretzki E, Mondry A, Vossough thyroid hormone assay to predict severe postoperative
A, Grabensee B, et al. Operative treatment of renal auton- hypocalcemia after reoperation for hyperparathyroidism.
omous hyperparathyroidism: cause of persistent or recur- Surgery 2002;132:1028-33;discussion 1033–4.